Patents
- Morgan, TM, inventor; Lachesis Biosciences Ltd, assignee. Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders. United States patent no. 10,471,040
- Morgan, TM, inventor; Lachesis Biosciences Ltd, assignee. Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders. WIPO PCT patent application WO 2016/049700. 2016 Apr 7.
- Morgan, TM, inventor; Lachesis Biosciences Ltd, assignee. Home diagnostic system. United States patent no. 8,388,532
Journal Publication
- Morgan TM, Soh B. Absolute Bioavailability and Safety of a Novel Rivastigmine Nasal Spray in Healthy Elderly Individuals. Br J Clin Pharmacol. 2017 83(3):510-516 PMID: 27639640 DOI: 10.1111/bcp.13133
Conference Posters
- Morgan TM. Deconvolution of Nasal Absorption of Rivastigmine in Humans and Future Clinical Development. J Prev Alz Dis 2016. 3(4):353; P2-39.
- Morgan TM. Absolute bioavailability and safety of a novel rivastigmine intranasal spray in healthy elderly individuals. J Prev Alz Dis 2015. 2(4):269-396; P2-55.